From Management to Cure: The Shifting Paradigm in HIV and Chronic Viral Hepatitis

Daniel Sepúlveda-Crespo1, Salvador Resino1

  • 1Centro Nacional de Microbiología, Instituto de Salud Carlos III, Carretera Majadahonda-Pozuelo, Km 2.2, 28220 Madrid, Spain.

Insights

Managing human immunodeficiency virus (HIV) and chronic viral hepatitis (HBV, HCV, HDV) infections presents a major global health challenge. Effective strategies are crucial for improving patient outcomes and public health.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Virology

Background:

  • Human immunodeficiency virus (HIV) and chronic viral hepatitis (Hepatitis B virus - HBV, Hepatitis C virus - HCV, and Hepatitis D virus - HDV) infections represent a significant global health burden.
  • Co-infection with HIV and viral hepatitis is common and complicates treatment and prognosis.
  • The development of novel therapeutic strategies and integrated management approaches is essential.

Discussion:

  • Concurrent infections with HIV and viral hepatitis necessitate tailored treatment protocols.
  • Understanding the complex interplay between these viruses is key to effective management.
  • Integrated care models can improve treatment adherence and health outcomes for co-infected patients.

Key Insights:

  • Integrated management of HIV and viral hepatitis co-infections is critical for patient survival.
  • Advances in antiviral therapies offer new hope for managing these complex conditions.
  • Public health initiatives focusing on prevention, screening, and treatment are vital.

Outlook:

  • Future research should focus on developing curative therapies for viral hepatitis and improving long-term HIV management.
  • Enhanced collaboration between infectious disease specialists and hepatologists will be crucial.
  • Policy interventions aimed at increasing access to diagnostics and treatment are needed globally.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.9K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
128
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.7K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
239
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
224